Jing Jiang
No ORCID on file
· 12 papers in corpus
· active 2001-2025
Study types
- article 6
- erratum 1
- other 1
- preprint 1
Condition tags
- endometriosis 7
- adenomyosis 2
- dysmenorrhea 1
- endometrioma 1
Top journals
Frequent coauthors
- Jiang J 8
- Gou Y 4
- Wang H 4
- Honglin Wang 4
- Liu J 4
- Cao Y 3
- Ning Wang 3
- Feng X 3
- Jinming Liu 3
- Liang Z 3
erratum
2025
2024
article
2024
OBJECTIVE: This study aimed to assess the knowledge, attitudes and practices (KAP) among Chinese reproductive-age women toward uterine adenomyosis. METHODS: This web-based cross-sectional study was conducted between April 2023 and Septembe…
article
2023
To explore the association between exposure to polycyclic aromatic hydrocarbons (PAHs) and endometriosis risk. Data were obtained from the 2003-2006 National Health and Nutrition Examination Survey database. Urinary concentrations of PAHs w…
article
2023
Endometriosis is a gynecological inflammatory disease that is linked with immune cells, specifically macrophages. IL-33 secreted from macrophages is known to accelerate the progression of endometriosis. The periodic and repeated bleeding th…
preprint
2023
Abstract Endometriosis is a gynecological inflammatory disease which linked with immune cells, specifically macrophages. And IL-33 secreted from macrophages is known to accelerate the progression of endometriosis. The periodic and repeated …
article
2019
To evaluate the clinical efficacy and safety of adenomyomectomy using "H" type incision combined with Mirena (LNG-IUS) in the treatment of adenomyosis.A total of 57 women with adenomyosis who underwent adenomyomectomy using "H" type incisio…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
other
2002
OBJECTIVE: To investigate the expressions of estrogen (E) receptor and progesterone (P) receptor in human eutopic and ectopic endometrium and the effect of mifepristone (RU486) on them. DESIGN: Prospective study. SETTING: University hospi…
article
2001
OBJECTIVE: To investigate the effects of mifepristone on expression of estrogen receptor (ER) and progesterone receptor (PR) in cultured human eutopic and ectopic endometria. METHODS: Endometrial (n = 22) and endometriotic (n = 12) tissues,…
article
2001
OBJECTIVE: To compare the efficacy and safety of mifepristone and danazol after conservative surgery in the treatment of patients with endometriosis. METHODS: Sixty-one patients with endometriosis (RAFS stage I-IV ) after conservative surge…